Bookmark

Add to MyYahoo RSS

Perrigo News

News on Perrigo (Ticker: PRGO) continually updated from thousands of sources around the net.

Yesterday | Hispanic Business

Perrigo Company plc Announces Quarterly Dividend

The Company is the world's largest manufacturer of OTC healthcare products for the store brand market and an industry leader in pharmaceutical technologies.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Multiple Sclerosis, Health

Mon Aug 18, 2014

AmericanBankingNews.com

Perrigo Company PLC Stock Rating Reaffirmed by Zacks

's stock had its "neutral" rating reaffirmed by Zacks in a research note issued on Monday.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Sleep Solutions

Sun Aug 17, 2014

Seeking Alpha

Perrigo Shines Again: Digging Into Perrigo Company's Q4 2014 And FY 2014 Earnings Report

While Q3 CHC revenue was flat due to the weak flu season, Q4 CHC revenue grew 8%.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Sleep Solutions, Influenza, Health, Biogen Idec

Fri Aug 15, 2014

AmericanBankingNews.com

Perrigo Company PLC Upgraded to Buy at B. Riley

The firm currently has a $180.00 price target on the stock, up from their previous price target of $157.00.

Comment?

Related Topix: Biotech, Sleep Solutions, Medicine, Healthcare Industry, Stanley

Thu Aug 14, 2014

Forbes.com

Thursday Sector Leaders: Utilities, Healthcare

The best performing sector as of midday Thursday is the Utilities sector, higher by 0.9%.

Comment?

Related Topix: Pinnacle West Capital Corporation, Energy, Duke Energy, Financial Markets, Biotech, Medicine, Amgen, Healthcare Industry

Seeking Alpha

Perrigo's (PRGO) CEO Joe Papa on Q4 2014 Results - Earnings Call Transcript

Good morning. My name is Lindsay and I will be your conference operator today. At this time, I would like to welcome everyone to Perrigo's Fiscal 2014 Fourth Quarter Earnings Results Conference Call.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

MLive.com

Perrigo reports solid fourth-quarter and fiscal 2014 sales and earnings

For the quarter, the period ended June 28, the generic pharmaceuticals and store-brand products maker reported net income of $131.7 million, up 11 percent from $118.5 million in the fourth quarter of its 2013 fiscal year.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

TheStreet.com

Why Perrigo (PRGO) Stock Is Rising Today

The global healthcare supplier reported an 18% rise in fourth quarter sales to $1.14 billion, ahead of analysts expectations of $1.09 billion.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Financial Markets, Warren Buffett

Investor's Business Daily

Perrigo Q4 Beats Estimates, But Guidance Misses

Sales for the quarter ended June 28 rose 18% over the year-earlier quarter to $1.14 billion, beating analysts' consensus of $1.09 billion.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Hispanic Business

Perrigo Co PLC Files (8-K) Disclosing Results of Operations and...

The press release related to the Company's earnings is attached as Exhibit 99.1. The earnings release contains certain non-GAAP measures.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Wed Aug 13, 2014

AmericanBankingNews.com

Perrigo Company PLC (PRGO) Scheduled to Post Quarterly Earnings on Thursday

Perrigo Company PLC will be announcing its Q414 earnings results on Thursday, August 14th.

Comment?

Related Topix: Biotech, Sleep Solutions, Medicine, Healthcare Industry, Stanley

Tue Aug 12, 2014

MLive.com

Perrigo to release fourth-quarter and full-year 2014 sales and earnings on Thursday

Store-brand products maker Perrigo Co. PLC is set to release fourth-quarter and full-year financial results for its 2014 fiscal year on Thursday .

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Allegan County, MI

MarketNewsVideo

S&P 500 Movers: PRGO, EA

In early trading on Tuesday, shares of Electronic Arts topped the list of the day's best performing components of the S&P 500 index, trading up 1.9%.

Comment?

Related Topix: Biotech, Sleep Solutions, Medicine, Healthcare Industry, Business News, Video

Mon Aug 11, 2014

Sys-Con Media

If You Purchased Certain Glucosamine And Chondroitin Products You...

Walgreen Co., Wal-Mart Stores, Inc., Supervalu, Inc., and Perrigo Company of A class action settlement has been preliminarily approved by the Court in the Action.

Comment?

Related Topix: Walgreens, Retail, Wal Mart Stores, Biotech, Medicine, Healthcare Industry

Sun Aug 10, 2014

AmericanBankingNews.com

Perrigo Company PLC Receives Consensus Rating of "Buy" from Analysts

Perrigo Company PLC has earned an average rating of "Buy" from the fourteen ratings firms that are currently covering the stock, American Banking & Market News reports .

Comment?

Related Topix: Biotech, Sleep Solutions, Medicine, Healthcare Industry

Thu Aug 07, 2014

Bloomberg

Yesterday's Inversion Buyers Are Next Targets

With a record number of U.S. tax-inversion deals shrinking the pool of possible targets, the next crop of acquirers may pursue their former American peers that have already reincorporated abroad.

Comment?

Related Topix: US News, US Senate, Democrat, US Politics, Barack Obama, Investment Banking, Jefferies Group, Investment Services, Financial Services, Biotech, Medicine, Healthcare Industry, Bristol Myers Squibb

Wed Jul 30, 2014

BioSpace

Perrigo Company Confirms First To File Patent Challenge For Generic...

This action formally initiates the process under the Hatch-Waxman Act. Perrigo believes that it is a first filer for this opportunity, entitling it to 180 days of generic exclusivity.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Food and Drug Administration, Topicort, Desoximetasone (generic), Corporate / Securities Law, Law

Mon Jul 28, 2014

BioSpace

Perrigo Company Confirms AB Therapeutic Equivalent Rating From The...

FDA concluded that Perrigo's testosterone product is therapeutically equivalent to [AbbVie's] AndroGel 1% and can be substituted with the full expectation that it will produce the same clinical effect and safety profile as AndroGel 1% when used under the conditions specified in the labeling.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Food and Drug Administration, Corporate / Securities Law, Law

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••